SEC Form D private-offering filing

Aspicio Therapeutics, Inc.

A new SEC Form D private-offering notice from Downingtown, PA, a $200,000 filer-stated offering target in Biotech. The source filing is one click away.

Aspicio Therapeutics, Inc. Verified via SEC Form D

Aspicio Therapeutics is a stealth stage, Downingtown, Pennsylvania based biologic therapy developer working on a treatment intended to promote synaptogenesis and address vision loss in dry age related macular degeneration.

Filed 5 days agoFiled to raise $200,000First money in 2026-07-16Raised so far $200,000HQ (as filed) Downingtown, PASector Biotech ✓Stage (inferred) Pre-seedCall status Debt-only offering

Source linked the Form D on EDGAR↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.